The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDalata Hotel Gp Regulatory News (DAL)

Share Price Information for Dalata Hotel Gp (DAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 358.00
Bid: 330.00
Ask: 386.00
Change: 0.00 (0.00%)
Spread: 56.00 (16.97%)
Open: 358.00
High: 0.00
Low: 0.00
Prev. Close: 358.00
DAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dalata Hotel Group PLC: Purchase of new London Hotel

16 Feb 2023 07:00

Dalata Hotel Group PLC (DAL,DHG) Dalata Hotel Group PLC: Purchase of new London Hotel 16-Feb-2023 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


 

Dalata Hotel Group announces purchase of new London hotel for £44.3 million

The Group’s first Maldron Hotel in London

 

ISE: DHG              LSE: DAL

Dublin and London | 16 February 2023: Dalata Hotel Group plc ("Dalata" or "the Group"), the largest hotel operator in Ireland, with a growing presence in the United Kingdom and continental Europe, is pleased to announce the addition of a new 192-bedroom hotel at 240 Seven Sisters Road, Finsbury Park, North London to its hotel portfolio. Under the transaction, Dalata has acquired the entire issued share capital of Tide Developments (4) Limited (“TD4”) for a total consideration of £44.3 million (€49.7 million) from Furadino Holdings Limited. TD4 has a gross asset value of £45.1 million and owns the freehold interest of the hotel property. The total consideration will be financed from Dalata’s existing cash and banking facilities.

The newly finished hotel, which has never traded, consists of 192 bedrooms, ground floor lobby and a restaurant and bar. Prior to opening in summer 2023, Dalata will invest in excess of £2 million to enhance the property and launch under the Maldron brand. The hotel, with an expectation of stabilised annual earnings of £4 million, will be Dalata’s first Maldron hotel in London, its 18th hotel in the UK and will create over 50 jobs locally. Conveniently located within walking distance of the Emirates Stadium, the hotel is adjacent to Finsbury Park Station, with extensive National Rail, London Underground and bus services offering direct links to King’s Cross St Pancras and the centre of London.

The property was constructed using the Vision Modular System, which can result in as much as a 40 per cent saving in the embodied carbon emissions when compared with traditional methods of construction. The sustainably designed hotel is BER A rated, includes photovoltaic panels, and is expected to achieve BREEAM ‘Excellent’ accreditation.

Dermot Crowley, CEO, Dalata commented on the announcement:

“London is a key strategic growth market for Dalata. We are very excited to be opening our first Maldron hotel in the city in advance of our Maldron in Shoreditch which is currently under construction. This acquisition represents an outstanding opportunity to operate a new, sustainably built, hotel in a vibrant and developing area as we continue our ambitious UK expansion plan. The strength of our balance sheet has been a crucial element in enabling us to make this investment as we continue to create value for all of our stakeholders.”

Shane Casserly, Corporate Development Director, Dalata added:

“Acquiring a new hotel asset in London, in challenging funding markets, that will be operational in the summer of 2023, is a fantastic achievement by the Group. This transaction highlights our appetite for growth as well as the flexibility of our business model, which enables us to grow through acquisition, development and leasing. We are excited by the excellent sustainability credentials of the property as we continue to make progress on our ambitious targets.”

ENDS

 

About Dalata

Dalata Hotel Group plc was founded in August 2007, listed as a plc in March 2014 and is now Ireland’s largest hotel operator, with a growing presence in the UK and continental Europe. The Group operates two primary hotel brands, Clayton Hotels and Maldron Hotels. The Group’s portfolio comprises 50 primarily 4-star hotels situated in city-centre locations with over 10,950 rooms across 29 owned hotels, 18 leased hotels and three management contracts. The Group has ambitious expansion plans for the UK and continental Europe with a committed pipeline of over 1,300 rooms. For the first six months of 2022, Dalata reported revenue of €220.2 million and a profit after tax of €46.7 million. Dalata is listed on the Main Market of Euronext Dublin (DHG) and the London Stock Exchange (DAL). For further information visit: www.dalatahotelgroup.com

 

Contacts

Dalata Hotel Group plc

Tel +353 1 206 9400

Dermot Crowley, CEO

investorrelations@dalatahotelgroup.com

Shane Casserly, Corporate Development Director

Carol Phelan, CFO

 Graham White, Head of Investor Relations

 

Joint Company Brokers

 

Davy: Anthony Farrell

Tel +353 1 679 6363

Berenberg: Ben Wright

Tel +44 20 3753 3069

 

 

Investor Relations and PR | FTI Consulting

Tel +353 86 401 5250

Melanie Farrell

dalata@fticonsulting.com

 

__________________________

 

 


ISIN:IE00BJMZDW83, IE00BJMZDW83
Category Code:ACQ
TIDM:DAL,DHG
LEI Code:635400L2CWET7ONOBJ04
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.:223503
EQS News ID:1561077
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
20th Dec 201812:00 pmRNSHolding(s) in Company
18th Dec 20187:00 amRNSTrading Update
12th Dec 20183:33 pmRNSHolding(s) in Company
3rd Dec 20188:57 amRNSTotal Voting Rights
30th Nov 20184:53 pmRNSDirector/PDMR Shareholding
30th Nov 20182:22 pmRNSHolding(s) in Company
23rd Nov 20182:12 pmRNSDirector/PDMR Shareholding
23rd Nov 20182:11 pmRNSDirector/PDMR Shareholding
23rd Nov 20182:10 pmRNSDirector/PDMR Shareholding
23rd Nov 201812:27 pmRNSHolding(s) in Company
16th Nov 20184:51 pmRNSAcquisition
12th Nov 201811:57 amRNSHolding(s) in Company
8th Nov 20187:00 amRNSStatement re Block Listing Application
5th Nov 20184:15 pmRNSStatement re Refinancing
30th Oct 20188:58 amRNSHolding(s) in Company
1st Oct 20183:00 pmRNSTotal Voting Rights
28th Sep 20184:35 pmRNSHolding(s) in Company
20th Sep 201810:10 amRNSDirector/PDMR Shareholding
17th Sep 201810:02 amRNSConversion Rate for 2018 Interim Dividend
7th Sep 20189:22 amRNSDirector/PDMR Shareholding
7th Sep 20187:00 amRNSDirector/PDMR Shareholding
4th Sep 20187:00 amRNSHalf-year Report
3rd Sep 20182:41 pmRNSTotal Voting Rights
30th Aug 201812:50 pmRNSHolding(s) in Company
29th Aug 20187:00 amRNSAcquisition of London Hotel
1st Aug 20189:13 amRNSTotal Voting Rights
25th Jul 201812:09 pmRNSHolding(s) in Company
25th Jul 20187:00 amRNSNotice of Results
23rd Jul 20182:39 pmRNSHolding(s) in Company
2nd Jul 201810:20 amRNSTotal Voting Rights
6th Jun 20183:55 pmRNSTotal Voting Rights
6th Jun 20187:00 amRNSMain Securities Market Notice
5th Jun 20187:00 amRNSBlocklisting Application
16th May 20187:00 amRNSAnnounces Two New Hotels in Bristol & Birmingham
3rd May 20184:18 pmRNSResult of AGM
3rd May 20187:00 amRNSAGM Statement
1st May 20188:27 amRNSTotal Voting Rights
11th Apr 20183:20 pmRNSDirector/PDMR Shareholding
10th Apr 20188:12 amRNSHolding(s) in Company
10th Apr 20187:00 amRNSMain Securities Market Notice
9th Apr 20182:00 pmRNSBlock Listing Application
3rd Apr 20184:35 pmRNSPrice Monitoring Extension
3rd Apr 20189:14 amRNSTotal Voting Rights
29th Mar 20185:00 pmRNSAnnual Financial Report
21st Mar 20183:59 pmRNSDirector/PDMR Shareholding
20th Mar 20183:55 pmRNSHolding(s) in Company
12th Mar 20183:51 pmRNSDirector/PDMR Shareholding
1st Mar 20181:34 pmRNSTotal Voting Rights
27th Feb 20187:00 amRNSFinal Results
12th Feb 20187:45 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.